Two biotechs raise a combined $556M in latest spurt of IPOs
Seaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that collectively raised almost $3.2 billion.
ORIGINAL SOURCE →via Biopharma Dive
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · US
- [HEALTH] Return on investment of community health workers in the United States: a systematic review.
- [HEALTH] [Correspondence] Will the USA lose its measles elimination status?
- [SPORTS] Wild def. Stars for 1st playoff series win since '...
- [CONFLICT] Clark's Fever homecoming soured by early exit
- [ENERGY] Organizing flash messages in Phoenix
- [CONFLICT] Good night, Bluesky!